Investing Ideas
/
Hong Kong Pharmaceuticals & Biotech High Quality Undervalued Stocks

Hong Kong Pharmaceuticals & Biotech High Quality Undervalued Stocks

Results

0 new

This selection of undervalued companies are the market's hidden engines of wealth. Not only do they combine good cash flows with and a solid balance sheet, but they are also poised for a breakout.

3 companies

Innovent Biologics

Market Cap: HK$163.3b

A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, Europe, and internationally.

1801

HK$93.80

-1.1%

-3.8%

WuXi XDC Cayman

Market Cap: HK$78.6b

An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.

2268

HK$62.05

0.2%

-0.3%

Biocytogen Pharmaceuticals (Beijing)

Market Cap: HK$65.7b

A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.

2315

HK$69.00

11.7%

180.0%